vTv Therapeutics (VTVT) Reports Q2 Loss of $0.47/Share

August 16, 2016 7:28 AM EDT
Get Alerts VTVT Hot Sheet
Price: $5.30 -1.67%

Today's EPS Names:
Trade VTVT Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.47). Revenue for the quarter came in at $182 thousand, versus $110 thousand reported last year.

Cash, cash equivalents and marketable securities as of June 30, 2016 were $63.8 million, compared to $88.0 million as of December 31, 2015. The Company expects that its cash, cash equivalents and marketable securities will be sufficient to fund its operations through at least mid-2017.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment